HUMAN FAS POLYMORPHISM IN DISEASE
HUMAN FAS POLYMORPHISM IN DISEASE
批准号:
2083230
负责人:
PATRICIA Ann FRASER
金额:
$23.08万
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-09-30 至 1997-05-31
中文摘要
描述:(改编自申请人摘要)动物模型
表明不同的遗传因素影响易感性,
自身免疫性疾病和疾病发作的时间。 自身免疫
MRL鼠品系的病症类似于SLE。 的lpr
小鼠Fas基因中的(淋巴增殖性)突变加速了
MRL-lpr/lpr小鼠中狼疮的发作。 有基因的影响,
对人类SLE的易感性 人类狼疮的早期发作也会发生。
虽然没有排除环境加速因素,
遗传成分加速或早发性SLE的建议,其
在某些种族群体中占主导地位。非裔美国人患SLE的年龄为
比美国白种人年轻得多。 除了有
狼疮样疾病MRL-lpr/lpr小鼠也形成了一种独特的
淋巴组织增生性疾病,其在人类中具有对应物,
儿童期发病综合征。
研究人员将检验人类基因多态性
Fas基因易患MRL-lpr/lpr综合征的人类类似物,
早发性SLE和青少年LPR疾病。 具体目标概述
实现这一目标的策略:(1)Fas多态性
与SLE的发病年龄相关
在其他种族群体和青少年lpr疾病中发病? (2)什么
是a)该Fas多态性的分子基础和B)其
功能相关物? (3)Fas的遗传方式是什么
多态性?以及(4)人类Fas的基因组结构是如何影响Fas的表达的?
正常人与SLE及幼年型lpr患者的基因比较
疾病
英文摘要
DESCRIPTION: (Adapted from the applicant's abstract) Animal models
demonstrate different genetic factors which influence predisposition to
autoimmune disease and the timing of disease onset. The autoimmune
disorder of the MRL murine strain resembles SLE. The lpr
(lymphoproliferative) mutation in the murine Fas gene accelerates the
onset of lupus in MRL-lpr/lpr mice. There are genetic influences on
susceptibility to human SLE. Early onset of human lupus also occurs.
Although environmental accelerating factors have not been excluded, a
genetic component to accelerated or early onset SLE is suggested by its
predominance in some ethnic groups.African-Americans develop SLE at a
significantly younger age than do U.S. Caucasians. In addition to the
lupus-like disease MRL-lpr/lpr mice also develop a unique
lymphoproliferative disease which has its human counterpart in a
childhood onset syndrome.
The investigators will test the hypothesis that polymorphism in the human
Fas gene predisposes to the human analogs of MRL-lpr/lpr syndromes,
early onset SLE, and juvenile lpr disease. The specific aims outline
strategies to accomplish this goal: (1) Does the Fas polymorphism
associated with early onset SLE in Blacks correlate with age of SLE
onset in other ethnic groups and with juvenile lpr disease? (2) What
is the a) the molecular basis for this Fas polymorphism and b) its
functional correlate(s)? (3) What is the mode of inheritance of the Fas
polymorphism? and (4) How does the genomic organization of the human Fas
gene compare in normal individuals and those with SLE and juvenile lpr
disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Innate immune gene SNPS in African-Americans with RA
-
批准号:6704095
-
项目类别:
-
资助金额:$28.35万
-
财政年份:2004
-
负责人:PATRICIA Ann FRASER
-
依托单位:
Innate immune gene SNPS in African-Americans with RA
-
批准号:6881412
-
项目类别:
-
资助金额:$28.35万
-
财政年份:2004
-
负责人:PATRICIA Ann FRASER
-
依托单位:
COMMUNITY OUTREACH FOR CTD SCREENING IN HIGH RISK GROUPS
-
批准号:6525225
-
项目类别:
-
资助金额:$31.92万
-
财政年份:2000
-
负责人:PATRICIA Ann FRASER
-
依托单位:
COMMUNITY OUTREACH FOR CTD SCREENING IN HIGH RISK GROUPS
-
批准号:6503368
-
项目类别:
-
资助金额:$3.39万
-
财政年份:2000
-
负责人:PATRICIA Ann FRASER
-
依托单位:
COMMUNITY OUTREACH FOR CTD SCREENING IN HIGH RISK GROUPS
-
批准号:6382365
-
项目类别:
-
资助金额:$31.92万
-
财政年份:2000
-
负责人:PATRICIA Ann FRASER
-
依托单位:
COMMUNITY OUTREACH FOR CTD SCREENING IN HIGH RISK GROUPS
-
批准号:6128746
-
项目类别:
-
资助金额:$31.92万
-
财政年份:2000
-
负责人:PATRICIA Ann FRASER
-
依托单位:
GENES AND CHEMICAL EXPOSURE ASSOCIATED WITH SLE RISK
-
批准号:6178202
-
项目类别:
-
资助金额:$19.24万
-
财政年份:1999
-
负责人:PATRICIA Ann FRASER
-
依托单位:
GENES AND CHEMICAL EXPOSURE ASSOCIATED WITH SLE RISK
-
批准号:6078923
-
项目类别:
-
资助金额:$19.24万
-
财政年份:1999
-
负责人:PATRICIA Ann FRASER
-
依托单位:
GENES AND CHEMICAL EXPOSURE ASSOCIATED WITH SLE RISK
-
批准号:6382345
-
项目类别:
-
资助金额:$19.24万
-
财政年份:1999
-
负责人:PATRICIA Ann FRASER
-
依托单位:
ANDROGEN GENE RECEPTOR POLYMORPHIMSMS AND AUTOIMMUNITY
-
批准号:2673159
-
项目类别:
-
资助金额:$4.99万
-
财政年份:1997
-
负责人:PATRICIA Ann FRASER
-
依托单位:
ANDROGEN GENE RECEPTOR POLYMORPHIMSMS AND AUTOIMMUNITY
-
批准号:2464632
-
项目类别:
-
资助金额:$4.99万
-
财政年份:1997
-
负责人:PATRICIA Ann FRASER
-
依托单位:
HUMAN FAS POLYMORPHISM IN DISEASE
-
批准号:2083231
-
项目类别:
-
资助金额:$23.11万
-
财政年份:1994
-
负责人:PATRICIA Ann FRASER
-
依托单位:
HUMAN FAS POLYMORPHISM IN DISEASE
-
批准号:2083229
-
项目类别:
-
资助金额:$22.68万
-
财政年份:1994
-
负责人:PATRICIA Ann FRASER
-
依托单位:
海外基金